| 6.90 Data as of 3:50pm ET |  +0.25 / +3.76%Today’s Change | 4.30 Today|||52-Week Range 16.68 | -3.77% Year-to-Date |
| 5 Stocks Setting Up to Break Out May 17 / TheStreet.com | Narrower-than-Expected Loss at Supernus - Analyst Blog May 14 / Zacks.com |
| Previous close | 6.65 |
| Today’s open | 6.60 |
| Day’s range | 6.56 - 6.90 |
| Volume | 549,046 |
| Average volume (3 months) | 536,126 |
| Market cap | $206.1M |
| Dividend yield | -- |
| Earnings growth (last year) | -165.83% |
| Earnings growth (this year) | +9.43% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +84.31% |
| P/E ratio | NM |
| Price/Sales | 84.49 |
| Price/Book | 3.54 |
| Today’s change | Today’s % change | |
|---|---|---|
| PGNXProgenics Pharmaceut... | +0.08 | +2.09% |
| VNDAVanda Pharmaceutical... | +1.22 | +17.14% |
| --Genufood Energy Enzy... | 0.00 | 0.00% |
| GALEGalena Biopharma Inc | -0.04 | -1.35% |
| Next reporting date | August 9, 2013 |
| EPS forecast (this quarter) | -$0.66 |
| Annual revenue (last year) | $1.5M |
| Annual profit (last year) | -$46.3M |
| Net profit margin | -3,127.30% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
President, Chief Executive Officer & Director Jack A. Khattar, MBA |
CFO, Vice President & Head-Investor Relations Gregory S. Patrick, MBA |
Corporate headquarters Rockville, Maryland |
.
